Beijing Xinghui Regeneration Technology

Beijing Xinghui Regeneration Technology is a pioneering biotechnology company dedicated to the field of regenerative medicine through in vivo cell transdifferentiation. Founded by Dr. Zhao Yang from Peking University, the company utilizes a proprietary platform that employs small molecule cocktails to reprogram existing somatic cells into functional therapeutic cells within the patient's body. This innovative approach bypasses the need for external cell transplantation, potentially reducing immunogenicity and complex manufacturing hurdles. The company's primary research focus includes the regeneration of inner ear hair cells for hearing loss and retinal cells for vision restoration. Xinghui is also exploring applications in metabolic diseases, such as regenerating pancreatic beta cells for diabetes treatment. By harnessing the body's innate regenerative capacity, the company aims to provide transformative treatments for previously irreversible degenerative conditions.